Hallux Valgus Epidemiology Forecast

DelveInsight's 'Hallux Valgus Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Hallux Valgus epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Study Period: 2017-2030


Hallux Valgus Understanding

The DelveInsight Hallux Valgus epidemiology report gives a thorough understanding of the Hallux Valgus by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Hallux Valgus in the US, Europe, and Japan. The report covers the detailed information of the Hallux Valgus epidemiology scenario in seven major countries (US, EU5, and Japan).


Hallux Valgus Epidemiology Perspective by DelveInsight

The Hallux Valgus epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Hallux Valgus epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Hallux Valgus epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Hallux Valgus Detailed Epidemiology Segmentation

The Hallux Valgus epidemiology covered in the report provides historical as well as forecasted Hallux Valgus epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Hallux Valgus report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


Scope of the Report

  • The Hallux Valgus report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Hallux Valgus Epidemiology Report and Model provide an overview of the risk factors and global trends of Hallux Valgus in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Hallux Valgus in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Hallux Valgus
  • The report provides the segmentation of the Hallux Valgus epidemiology


Report Highlights

  • 11-Year Forecast of Hallux Valgus epidemiology
  • 7MM Coverage
  • Total Cases of Hallux Valgus
  • Total Cases of Hallux Valgus according to segmentation
  • Diagnosed cases of Hallux Valgus


KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Hallux Valgus?
  • What are the key findings pertaining to the Hallux Valgus epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Hallux Valgus across the 7MM during the forecast period (2017-2030)?
  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Hallux Valgus?
  • What are the currently available treatments of Hallux Valgus?


Reasons to buy

  • The Hallux Valgus Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Hallux Valgus market
  • Quantify patient populations in the global Hallux Valgus market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Hallux Valgus therapeutics in each of the markets covered
  • Understand the magnitude of Hallux Valgus population by its epidemiology
  • The Hallux Valgus Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights 

2. Executive Summary of Hallux Valgus

3. Hallux Valgus: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Hallux Valgus Epidemiology Scenario in the 7MM (2017- 2030)

5.4. United States Epidemiology

5.4.1. Hallux Valgus Epidemiology Scenario in the United States (2017- 2030)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Hallux Valgus Epidemiology Scenario in Germany (2017- 2030)

5.5.2. France Epidemiology

5.5.2.1. Hallux Valgus Epidemiology Scenario in France (2017- 2030)

5.5.3. Italy Epidemiology

5.5.3.1. Hallux Valgus Epidemiology Scenario in Italy (2017- 2030)

5.5.4. Spain Epidemiology

5.5.4.1. Hallux Valgus Epidemiology Scenario in Spain (2017- 2030)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Hallux Valgus Epidemiology Scenario in the United Kingdom (2017-2030)

5.6. Japan Epidemiology

5.6.1. Hallux Valgus Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Hallux Valgus Treatment and Management

6.2. Hallux Valgus Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

Table 1  Hallux Valgus Epidemiology in 7MM (2017-2030)

Table 2 Hallux Valgus Diagnosed and Treatable Cases in 7MM (2017-2030)

Table 3 Hallux Valgus Epidemiology in the United States (2017-2030)

Table 4 Hallux Valgus Diagnosed and Treatable Cases in the United States (2017-2030)

Table 5 Hallux Valgus Epidemiology in Germany (2017-2030)

Table 6 Hallux Valgus Diagnosed and Treatable Cases in Germany (2017-2030)

Table 7 Hallux Valgus Epidemiology in France (2017-2030)

Table 8 Hallux Valgus Diagnosed and Treatable Cases in France (2017-2030)

Table 9 Hallux Valgus Epidemiology in Italy (2017-2030)

Table 10 Hallux Valgus Diagnosed and Treatable Cases in Italy (2017-2030)

Table 11 Hallux Valgus Epidemiology in Spain (2017-2030)

Table 12 Hallux Valgus Diagnosed and Treatable Cases in Spain (2017-2030)

Table 13 Hallux Valgus Epidemiology in the United Kingdom (2017-2030)

Table 14 Hallux Valgus Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Table 15 Hallux Valgus Epidemiology in Japan (2017-2030)

Table 16 Hallux Valgus Diagnosed and Treatable Cases in Japan (2017-2030)

Figure 1 Hallux Valgus Epidemiology in 7MM (2017-2030)

Figure 2 Hallux Valgus Diagnosed and Treatable Cases in 7MM (2017-2030)

Figure 3 Hallux Valgus Epidemiology in the United States (2017-2030)

Figure 4 Hallux Valgus Diagnosed and Treatable Cases in the United States (2017-2030)

Figure 5 Hallux Valgus Epidemiology in Germany (2017-2030)

Figure 6 Hallux Valgus Diagnosed and Treatable Cases in Germany (2017-2030)

Figure 7 Hallux Valgus Epidemiology in France (2017-2030)

Figure 8 Hallux Valgus Diagnosed and Treatable Cases in France (2017-2030)

Figure 9 Hallux Valgus Epidemiology in Italy (2017-2030)

Figure 10 Hallux Valgus Diagnosed and Treatable Cases in Italy (2017-2030)

Figure 11 Hallux Valgus Epidemiology in Spain (2017-2030)

Figure 12 Hallux Valgus Diagnosed and Treatable Cases in Spain (2017-2030)

Figure 13 Hallux Valgus Epidemiology in the United Kingdom (2017-2030)

Figure 14 Hallux Valgus Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Figure 15 Hallux Valgus Epidemiology in Japan (2017-2030)

Figure 16 Hallux Valgus Diagnosed and Treatable Cases in Japan (2017-2030)

*The table of contents is not exhaustive; will be provided in the final report


  • Tags:
  • Hallux Valgus Epidemiology
  • Hallux Valgus
  • Hallux Valgus Pipeline
  • Hallux Valgus Companies
  • Hallux Valgus prevalent population
  • Hallux Valgus incident population
  • Hallux Valgus patients diagnosed
  • Hallux Valgus treatment algorithm

Forward to Friend

Need A Quote